𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status

✍ Scribed by Yeon Hee Park; Soohyeon Lee; Eun Yoon Cho; Yoon La Choi; Jeong Eon Lee; Seok Jin Nam; Jung-Hyun Yang; Jin Seok Ahn; Young-Hyuck Im

Publisher
Springer
Year
2009
Tongue
English
Weight
554 KB
Volume
66
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risk factors according to estrogen recep
Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India
✍ Subhojit Dey; Paolo Boffetta; Anitha Mathews; Paul Brennan; Amr Soliman; Aleyamm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 101 KB πŸ‘ 1 views

## Abstract Estrogen receptor (ER) status is an important biomarker in defining subtypes of breast cancer differing in antihormonal therapy response, risk factors and prognosis. However, little is known about association of ER status with various risk factors in the developing world. Our case–contr

Body-size indicators and risk of breast
Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status
✍ Satu MΓ€nnistΓΆ; Pirjo Pietinen; Marjo Pyy; Juni Palmgren; Matti Eskelinen; Matti πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 597 KB

Associations between the risk of breast cancer and body-size indicators at the time of breast-cancer diagnosis were assessed among 328 pre-menopausal or post-menopausal cases and 4 I7 controls participating in the Kuopio Breast Cancer Study. This case-control study follows the protocol of the intern

Influence of estrogen receptor status on
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy
✍ Dr. Bellarmine V. Lawrence; Allan Lipton; Harold A. Harvey; Richard J. Santen; S πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 563 KB

Aminoglutethimide (AG) is an effective chemical ablative form of therapy for metastatic breast cancer in postmenopausal women. Estrogen receptor (ER) status in breast cancer is useful in predicting the response to the hormonal treatments. Of 134 postmenopausal metastatic breast cancer patients treat